Nothing Special   »   [go: up one dir, main page]

SE7704616L - Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat - Google Patents

Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat

Info

Publication number
SE7704616L
SE7704616L SE7704616A SE7704616A SE7704616L SE 7704616 L SE7704616 L SE 7704616L SE 7704616 A SE7704616 A SE 7704616A SE 7704616 A SE7704616 A SE 7704616A SE 7704616 L SE7704616 L SE 7704616L
Authority
SE
Sweden
Prior art keywords
group
desoxy
prostaglandin
derivatives
way
Prior art date
Application number
SE7704616A
Other languages
English (en)
Other versions
SE436037B (sv
Inventor
J Buendia
J Nierat-Schalbar
R Deroy
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7612942A external-priority patent/FR2349328A1/fr
Priority claimed from FR7701299A external-priority patent/FR2377395A2/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SE7704616L publication Critical patent/SE7704616L/sv
Publication of SE436037B publication Critical patent/SE436037B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
SE7704616A 1976-04-30 1977-04-21 Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat SE436037B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7612942A FR2349328A1 (fr) 1976-04-30 1976-04-30 Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments
FR7701299A FR2377395A2 (fr) 1977-01-18 1977-01-18 Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
SE7704616L true SE7704616L (sv) 1977-10-31
SE436037B SE436037B (sv) 1984-11-05

Family

ID=26219428

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7704616A SE436037B (sv) 1976-04-30 1977-04-21 Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat

Country Status (14)

Country Link
US (1) US4119727A (sv)
JP (1) JPS52148048A (sv)
AR (1) AR222627A1 (sv)
AT (1) AT355739B (sv)
AU (1) AU511408B2 (sv)
CA (1) CA1100493A (sv)
CH (1) CH620675A5 (sv)
DE (1) DE2719244A1 (sv)
DK (1) DK187677A (sv)
GB (1) GB1538842A (sv)
IE (1) IE45141B1 (sv)
LU (1) LU77240A1 (sv)
NL (1) NL7704758A (sv)
SE (1) SE436037B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0282901U (sv) * 1988-12-12 1990-06-27
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
AR047894A1 (es) 2004-02-25 2006-03-01 Wyeth Corp Derivados de tiofeno como inhibidores de la proteina tirosina fosfatasa 1b (ptpasa 1b); metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por ptpasa 1b
WO2005081960A2 (en) * 2004-02-25 2005-09-09 Wyeth Inhibitors of protein tyrosine phosphatase 1b
US7183310B2 (en) 2004-08-10 2007-02-27 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7101904B2 (en) * 2004-08-10 2006-09-05 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7906552B2 (en) 2004-08-10 2011-03-15 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
NZ555945A (en) * 2005-01-14 2011-01-28 Allergan Inc Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions
DE602006018583D1 (de) * 2005-03-04 2011-01-13 Sucampo Ag Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
AU2006311942B2 (en) 2005-11-03 2012-11-22 Allergan, Inc. Prostaglandins and analogues as agents for lowering intraocular pressure
EP2291346A2 (en) * 2008-05-15 2011-03-09 Allergan, Inc. Therapeutic substituted cyclopentanes
US9695254B2 (en) 2012-11-26 2017-07-04 Braskem S.A. Metallocene catalyst supported by hybrid supporting means, process for producing same, polymerization process for producing an ethylene homopolymer or copolymer with broad or bimodal molar mass distribution, use of the supported metallocene catalyst and ethylene polymer with broad or bimodal molar mass distribution

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3776940A (en) * 1966-08-09 1973-12-04 G Just Intermediates for producing prostaglandins
US3956284A (en) * 1972-07-13 1976-05-11 Pfizer Inc. Heterocyclic 15-substituted-ω-pentanorprostoglandins
US3794664A (en) * 1972-08-17 1974-02-26 G Just Bicyclo(3.1.0)hexane intermediates for producing prostaglandins f1alpha and f1beta
US4387241A (en) * 1974-11-01 1983-06-07 American Cyanamid Company Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives

Also Published As

Publication number Publication date
AR222627A1 (es) 1981-06-15
AU2479577A (en) 1978-11-09
AU511408B2 (en) 1980-08-21
DE2719244A1 (de) 1977-11-17
DK187677A (da) 1977-10-31
JPS52148048A (en) 1977-12-08
IE45141B1 (en) 1982-06-30
NL7704758A (nl) 1977-11-01
SE436037B (sv) 1984-11-05
LU77240A1 (sv) 1977-12-13
US4119727A (en) 1978-10-10
GB1538842A (en) 1979-01-24
CH620675A5 (sv) 1980-12-15
IE45141L (en) 1977-10-30
ATA310177A (de) 1979-08-15
DE2719244C2 (sv) 1987-10-15
AT355739B (de) 1980-03-25
JPS6131103B2 (sv) 1986-07-17
CA1100493A (fr) 1981-05-05

Similar Documents

Publication Publication Date Title
SE8401134D0 (sv) Forfarande for framstellning av dihydro-cyklosporin d
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
SE8104132L (sv) Mjuka steroider med antiiflammatorisk verkan
SE8003815L (sv) Alkyl-ketohexopyranosid-derivat
SE7704616L (sv) Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat
SE7707341L (sv) 4-hydroxifenylalkanolamin-derivat och forfarande for framstellning derav
SE7602144L (sv) Kvaternera imidazoliumforeningar
SE7710873L (sv) Nya 1h-pyrazolo(3,4-b)pyridiner
ES555007A0 (es) Procedimiento para preparar compuestos de 5-alquil-1-fenil-2-piperazinoalquilpirazolin-3-ona.
FI830893L (fi) Nya fenylpiperazin-derivat samt deras framstaellningsfoerfarande
SE7713704L (sv) Propionsyraderivat och sett for framstellning av desamma
ES377662A1 (es) Procedimiento para la preparacion de nuevos compuestos de derivados de dialcohil-xantina.
SE8006953L (sv) Heterocykliska foreningar
SE7607088L (sv) 5-fluor-uracilderivat.
ES468127A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirido (2,1-b) quinazolina
GB2005246A (en) beta -Lactam compounds and processes for their preparation
SE7812371L (sv) Forfarande for framstellning av fenoxialkanolaminderivat
ES447751A1 (es) Procedimiento para preparar derivados de imidazolilquinazo- lina.
ES540260A0 (es) Procedimiento para preparar derivados de 2-alcoxiaminosulfo-nilbencenosulfonilurea
ES471267A1 (es) Procedimiento para la preparacion de alquilo inferior 2-tri-(inferior) alquilsililacetileno-n-carbetoxiglicinatos y ami-no acidos derivados de ellos
GB2003866A (en) Thiourea derivatives
SE7509069L (sv) Forfarande for framstellning av cyklopropylmetylamin-derivat.
ES460297A1 (es) Un compuesto.
SE7901316L (sv) Derivat av dehydrocykliciminsyror
ES458092A1 (es) Procedimiento para la obtencion de derivados de la n1, n4- dioxo-quinoxalina.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7704616-7

Effective date: 19910117

Format of ref document f/p: F